The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…
September 22, 2:01 PM
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 7.32% since its last report. The company recently reported that it has 12.94 million shares sold short, which is 0.76% of all regular shares that are available for trading.
September 9, 6:23 AM
The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories (NYSE: ABT) MitraClip's delivery system to stop heart valve leakage.
September 8, 4:25 PM